Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 1
1953 1
1954 1
1956 1
1957 2
1958 2
1959 1
1961 7
1962 6
1963 5
1964 6
1965 4
1966 7
1967 6
1968 6
1969 11
1970 8
1971 9
1972 19
1973 8
1974 9
1975 18
1976 13
1977 17
1978 16
1979 18
1980 17
1981 15
1982 16
1983 22
1984 17
1985 20
1986 19
1987 17
1988 18
1989 20
1990 22
1991 14
1992 22
1993 23
1994 32
1995 43
1996 41
1997 66
1998 50
1999 69
2000 66
2001 64
2002 61
2003 69
2004 82
2005 73
2006 72
2007 85
2008 88
2009 82
2010 78
2011 88
2012 110
2013 86
2014 99
2015 88
2016 107
2017 80
2018 108
2019 109
2020 103
2021 116
2022 107
2023 108
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

2,697 results

Results by year

Filters applied: . Clear all
Page 1
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.
Wada M, Noda Y, Iwata Y, Tsugawa S, Yoshida K, Tani H, Hirano Y, Koike S, Sasabayashi D, Katayama H, Plitman E, Ohi K, Ueno F, Caravaggio F, Koizumi T, Gerretsen P, Suzuki T, Uchida H, Müller DJ, Mimura M, Remington G, Grace AA, Graff-Guerrero A, Nakajima S. Wada M, et al. Mol Psychiatry. 2022 Jul;27(7):2950-2967. doi: 10.1038/s41380-022-01572-0. Epub 2022 Apr 20. Mol Psychiatry. 2022. PMID: 35444257 Review.
Foreword.
Wada M. Wada M. Chem Pharm Bull (Tokyo). 2023;71(1):9. doi: 10.1248/cpb.c23-ctf7101. Chem Pharm Bull (Tokyo). 2023. PMID: 36596516 Free article. No abstract available.
Pediatric intestinal rehabilitation.
Kudo H, Wada M. Kudo H, et al. Among authors: wada m. Curr Opin Organ Transplant. 2023 Jun 1;28(3):237-241. doi: 10.1097/MOT.0000000000001062. Epub 2023 Apr 12. Curr Opin Organ Transplant. 2023. PMID: 37053076 Review.
Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support.
Chiba M, Masumoto K, Kaji T, Matsuura T, Morii M, Fagbemi A, Hill S, Pakarinen MP, Protheroe S, Urs A, Chen ST, Sakui S, Udagawa E, Wada M. Chiba M, et al. Among authors: wada m. J Pediatr Gastroenterol Nutr. 2023 Sep 1;77(3):339-346. doi: 10.1097/MPG.0000000000003867. Epub 2023 Jun 26. J Pediatr Gastroenterol Nutr. 2023. PMID: 37364133 Free PMC article. Clinical Trial.
The Authors' Reply.
Mori D, Kobayashi M, Wada M, Tokuchi M, Misegawa S, Saito R, Nomi H, Haga R, Nagatoya K, Yamauchi A. Mori D, et al. Among authors: wada m. Intern Med. 2024 Jan 2. doi: 10.2169/internalmedicine.3074-23. Online ahead of print. Intern Med. 2024. PMID: 38171866 Free article. No abstract available.
Authors' reply.
Wakasugi M, Yokoseki A, Wada M, Momotsu T, Sato K, Kawashima H, Nakamura K, Onodera O, Narita I. Wakasugi M, et al. Among authors: wada m. J Bone Miner Metab. 2022 May;40(3):537-538. doi: 10.1007/s00774-022-01315-9. Epub 2022 Feb 20. J Bone Miner Metab. 2022. PMID: 35184207 No abstract available.
Severe Psychosis Associated With Lorlatinib.
Kunimasa K, Wada M, Nishino K. Kunimasa K, et al. Among authors: wada m. J Thorac Oncol. 2023 Jul;18(7):e71-e72. doi: 10.1016/j.jtho.2023.03.025. J Thorac Oncol. 2023. PMID: 37348995 No abstract available.
Untangling the threads of cellulose mercerization.
Sawada D, Nishiyama Y, Shah R, Forsyth VT, Mossou E, O'Neill HM, Wada M, Langan P. Sawada D, et al. Among authors: wada m. Nat Commun. 2022 Oct 19;13(1):6189. doi: 10.1038/s41467-022-33812-w. Nat Commun. 2022. PMID: 36261428 Free PMC article.
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.
Nakahara T, Tsugawa S, Noda Y, Ueno F, Honda S, Kinjo M, Segawa H, Hondo N, Mori Y, Watanabe H, Nakahara K, Yoshida K, Wada M, Tarumi R, Iwata Y, Plitman E, Moriguchi S, de la Fuente-Sandoval C, Uchida H, Mimura M, Graff-Guerrero A, Nakajima S. Nakahara T, et al. Among authors: wada m. Mol Psychiatry. 2022 Jan;27(1):744-757. doi: 10.1038/s41380-021-01297-6. Epub 2021 Sep 28. Mol Psychiatry. 2022. PMID: 34584230 Review.
2,697 results